Literature DB >> 3771619

Growth inhibition of experimental glioma grafts by monoclonal antibody treatment.

D Stavrou, W Mellert, U Mellert, E Keiditsch, K Bise, P Mehraein.   

Abstract

The effects of 14AC1 monoclonal antibody (McAb) on 79FR-G-41 rat glioma cells in vitro, on the formation of metastases in lung by antibody coated glioma cells, and on the growth of glioma grafts in BALB/c-nu/nu mice were investigated. The 14AC1 antibodies - isotyped as IgG2a - were obtained from a hybridoma clone established after fusion of X63-Ag8.653 myeloma cells and spleen cells of BALB/c mice hyperimmunized with 79FR-G-41 glioma cells. Antibody treatment of glioma cells in vitro caused evident cell surface alterations and pronounced growth depression of most cells. However, a few tumor cells remained unchanged in morphology and continued to proliferate. Moreover, 14AC1 antibodies drastically reduced lung metastasis by pretreated and i.v. delivered glioma cells. Additionally, 14AC1 antibodies suppressed the growth of transplanted rat gliomas in nude mice as evidenced by a longer latency period and a smaller volume of glioma grafts in treated than in control tumor bearers. Nevertheless, glioma grafts showed accelerated growth after termination of antibody treatment. Further experimental investigation is required in order to identify the precise mechanisms of the effects of McAbs on tumor cells in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771619     DOI: 10.1007/bf00404392

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

Review 2.  Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumors.

Authors:  D E Bullard; D D Bigner
Journal:  J Neurosurg       Date:  1985-07       Impact factor: 5.115

3.  The potential of monoclonal antibodies as carriers of radiation and drugs for immunodetection and therapy of brain tumors.

Authors:  M A Bourdon; R E Coleman; D D Bigner
Journal:  Prog Exp Tumor Res       Date:  1984

4.  Antigens on naturally occurring animal and human tumors detected by monoclonal antibodies.

Authors:  M J Embleton; B Gunn; V S Byers; R W Baldwin
Journal:  Transplant Proc       Date:  1981-12       Impact factor: 1.066

5.  Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.

Authors:  D M Herlyn; Z Steplewski; M F Herlyn; H Koprowski
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

6.  Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.

Authors:  R C Seeger; H M Rosenblatt; K Imai; S Ferrone
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

7.  Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.

Authors:  D O Adams; T Hall; Z Steplewski; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody.

Authors:  W G Dippold; A Knuth; K H Meyer zum Büschenfelde
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

9.  Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen.

Authors:  I D Bernstein; M R Tam; R C Nowinski
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

10.  Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.

Authors:  D Stavrou; W Mellert; T Bilzer; R Senekowitsch; E Keiditsch; P Mehraein
Journal:  Anticancer Res       Date:  1985 Mar-Apr       Impact factor: 2.480

View more
  3 in total

Review 1.  Monoclonal antibodies in neuro-oncology.

Authors:  D Stavrou
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

2.  Determination of subcutaneous tumor size in athymic (nude) mice.

Authors:  M M Tomayko; C P Reynolds
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  A microcomputer program for calculating cell population doubling time in vitro and in vivo.

Authors:  J I Zwicker; R T Proffitt; C P Reynolds
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.